Press & News
People are different and so is their cancer, patients should be treated individually.
New The power of precision, For Every Oncologist, Today
With IndiTreat, 2cureX makes the testing of chemotherapeutic agents on patient-derived microtumors an operational reality.
Read
Latest News
The latest news around the IndiTreat® clinical trial in colorectal cancer patients that met its primary endpoint.
Read more
Feb 2
News
RedEye interview with CEO Fernando Andreu and CSO Ole Thastrup
Jan 25
Ole Thastrup presents at the Virtual RedEye Fight Cancer 2021 meeting January 21st
Jan 5
2cureX appoints new CEO (BioStock)
Dec 23
Key achievements in 2020 – an IndiTreat® Launch year
Dec 22
2020 – Launch Year for IndiTreat (BioStock)
Dec 2
2cureX publishes Q3’20 report (Biostock)
Nov 26
2cureX launches new website
Nov 11
2cureX presents commercial roadmap 2021 – 2023
Get notified on mail, when news or press release is posted on our website
